Title:
COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING BONE LOSS DISEASES, COMPRISING CYCLO(HIS-PRO) (CHP)
Document Type and Number:
WIPO Patent Application WO/2019/098811
Kind Code:
A3
Abstract:
The present invention relates to a composition for preventing, alleviating, or treating bone loss diseases, comprising cyclo(His-Pro) (CHP), and more specifically to a composition for preventing, alleviating, or treating bone loss diseases, comprising CHP or a prostate extract comprising same.
Inventors:
JUNG HOE YUNE (KR)
LEE HEON JONG (KR)
LEE DO HYUN (KR)
LEE HEON JONG (KR)
LEE DO HYUN (KR)
Application Number:
PCT/KR2018/014275
Publication Date:
July 11, 2019
Filing Date:
November 20, 2018
Export Citation:
Assignee:
NOVMETAPHARMA CO LTD (KR)
International Classes:
A61K31/4985; A23L33/10; A23L33/105; A61K35/52; A61K36/48
Foreign References:
| KR20010022786A | 2001-03-26 | |||
| US20080242621A1 | 2008-10-02 |
Other References:
ANONYMOUS: "Pulse of Investment", FINDING OUT 'NOVMETAPHARMA, 16 January 2017 (2017-01-16), pages 1 - 7, XP055619077, Retrieved from the Internet
JANG, JONG WON.: "Nob Metapharma: Development of new drugs for diabetes and obesity with original technology of'Zinc'", BIOSPECTATOR, NOVMETAPHARMA, 2016, pages 1 - 4, XP009521225, ISSN: 2671-5139, Retrieved from the Internet
ANONYMOUS: "Hyundai Heavy Industries Group, Hi Investment & Securities Company Report", NOVMETAPHARMA (229500), 30 May 2016 (2016-05-30), pages 1 - 9, XP055619073, Retrieved from the Internet
JANG, JONG WON.: "Nob Metapharma: Development of new drugs for diabetes and obesity with original technology of'Zinc'", BIOSPECTATOR, NOVMETAPHARMA, 2016, pages 1 - 4, XP009521225, ISSN: 2671-5139, Retrieved from the Internet
ANONYMOUS: "Hyundai Heavy Industries Group, Hi Investment & Securities Company Report", NOVMETAPHARMA (229500), 30 May 2016 (2016-05-30), pages 1 - 9, XP055619073, Retrieved from the Internet
Attorney, Agent or Firm:
ERUUM & LEEON INTELLECTUAL PROPERTY LAW FIRM (KR)
Download PDF: